39 results
Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial
31 Jan 2020
In IVUS-XPL (Impact of Intravascular Ultrasound Guidance on the Outcomes of Xience Prime Stents in Long Lesions) trial the long-term outcomes of stent optimisation with IVUS were analysed.
Reviewer
Reviewer
Fractional flow reserve or optical coherence tomography to guide management of angiographically intermediate coronary stenosis: a single-center trial
21 Jan 2020
This study aimed at comparing the effects of fractional flow reserve- vs. optical coherence tomography-guided treatment of angiographically intermediate coronary stenosis.
Reviewer
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis
05 Nov 2019
A comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)
Reviewer
Reviewer
Ticagrelor with or without aspirin in high-risk patients after PCI
07 Oct 2019
The TWILIGHT trial was designed to test the hypothesis that in patients undergoing PCI who are at high risk for ischemic or hemorrhagic complications and who have completed a 3-month course of DAPT with ticagrelor plus aspirin, continued treatment with ticagrelor monotherapy would be superior to ticagrelor...
Reviewer
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial
16 Sep 2019
GLOBAL LEADERS was a randomized, open-label, superiority trial in patients who underwent PCI with a biolimus A9-eluting stent for stable CAD or ACS...
Reviewer
Reviewer
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
10 Jul 2019
The 2-year results of the SYNTAX II study seem to primarily underscore the potential to improve patient outcomes by refining the technique and technology of PCI.
Reviewer
Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention
09 Jul 2019
Results of the SMART-CHOICE randomized clinical trial
Reviewer
Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI
09 Jul 2019
Results of the STOPDAPT-2 randomized clinical trial
Reviewer
Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation (the AUGUSTUS trial)
19 Mar 2019
Reviewer
Reviewer
- ← previous
- 1
- 2
- 3
- 4
- next →